关注
Fernando Caravaca-Fontán
Fernando Caravaca-Fontán
Instituto de Investigación Hospital 12 de Octubre (imas12)
在 salud.madrid.org 的电子邮件经过验证
标题
引用次数
引用次数
年份
The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary …
G Fernández-Juárez, J Rojas-Rivera, AE van De Logt, J Justino, ...
Kidney international 99 (4), 986-998, 2021
1442021
Duration of treatment with corticosteroids and recovery of kidney function in acute interstitial nephritis
G Fernandez-Juarez, JV Perez, F Caravaca-Fontán, L Quintana, ...
Clinical Journal of the American Society of Nephrology 13 (12), 1851-1858, 2018
1082018
SARS-CoV-2 infection in hospitalized patients with kidney disease
H Trujillo, F Caravaca-Fontán, Á Sevillano, E Gutiérrez, J Caro, ...
Kidney International Reports 5 (6), 905-909, 2020
1072020
Severe and malignant hypertension are common in primary atypical hemolytic uremic syndrome
T Cavero, E Arjona, K Soto, F Caravaca-Fontan, C Rabasco, L Bravo, ...
Kidney international 96 (4), 995-1004, 2019
662019
Update on C3 glomerulopathy: a complement-mediated disease
F Caravaca-Fontán, L Lucientes, T Cavero, M Praga
Nephron 144 (6), 272-280, 2020
592020
Patterns of progression of chronic kidney disease at later stages
F Caravaca-Fontán, L Azevedo, E Luna, F Caravaca
Clinical kidney journal 11 (2), 246-253, 2018
532018
Mycophenolate mofetil in C3 glomerulopathy and pathogenic drivers of the disease
F Caravaca-Fontán, MM Díaz-Encarnación, L Lucientes, T Cavero, ...
Clinical Journal of the American Society of Nephrology 15 (9), 1287-1298, 2020
502020
RICORS2040: the need for collaborative research in chronic kidney disease
A Ortiz
Clinical kidney journal 15 (3), 372-387, 2022
472022
Acute kidney injury in interstitial nephritis
F Caravaca-Fontán, G Fernández-Juárez, M Praga
Current opinion in critical care 25 (6), 558-564, 2019
402019
Relative importance of the determinants of serum levels of 25-hydroxy vitamin D in patients with chronic kidney disease
F Caravaca-Fontán, B Gonzales-Candia, E Luna, F Caravaca
Nefrología (English Edition) 36 (5), 510-516, 2016
382016
Acute renal infarction: Clinical characteristics and prognostic factors
F Caravaca-Fontán, SP Saico, SE Trivino, CG Álvarez, AG Couto, ...
Nefrología (English Edition) 36 (2), 141-148, 2016
362016
IgA nephropathy in elderly patients
AM Sevillano, M Diaz, F Caravaca-Fontán, C Barrios, C Bernis, J Cabrera, ...
Clinical Journal of the American Society of Nephrology 14 (8), 1183-1192, 2019
332019
The forgotten antiproteinuric properties of diuretics
H Trujillo, F Caravaca-Fontán, J Caro, E Morales, M Praga
American Journal of Nephrology 52 (6), 435-449, 2021
322021
A meta-analysis of GFR slope as a surrogate endpoint for kidney failure
LA Inker, W Collier, T Greene, S Miao, J Chaudhari, GB Appel, SV Badve, ...
Nature medicine 29 (7), 1867-1876, 2023
292023
Spanish Group for the Study of Glomerular Diseases (GLOSEN): Duration of treatment with corticosteroids and recovery of kidney function in acute interstitial nephritis
G Fernandez-Juarez, JV Perez, F Caravaca-Fontán, L Quintana, ...
Clin J Am Soc Nephrol 13 (1851-1858), 10.2215, 2018
282018
Tocilizumab use in kidney transplant patients with COVID‐19
H Trujillo, F Caravaca‐Fontán, Á Sevillano, E Gutiérrez, ...
Clinical transplantation 34 (11), e14072, 2020
272020
Validation of a histologic scoring index for C3 glomerulopathy
F Caravaca-Fontan, H Trujillo, M Alonso, M Diaz-Encarnacion, V Cabello, ...
American Journal of Kidney Diseases 77 (5), 684-695. e1, 2021
262021
Invasive pulmonary aspergillosis associated with COVID‐19 in a kidney transplant recipient
H Trujillo, M Fernández‐Ruiz, E Gutiérrez, Á Sevillano, ...
Transplant Infectious Disease 23 (2), e13501, 2021
252021
Longitudinal change in proteinuria and kidney outcomes in C3 glomerulopathy
F Caravaca-Fontán, M Díaz-Encarnación, V Cabello, G Ariceta, ...
Nephrology Dialysis Transplantation 37 (7), 1270-1280, 2022
242022
High levels of both serum gamma-glutamyl transferase and alkaline phosphatase are independent predictors of mortality in patients with stage 4–5 chronic kidney disease
F Caravaca-Fontán, L Azevedo, MÁ Bayo, B Gonzales-Candia, E Luna, ...
Nefrología (English Edition) 37 (3), 267-275, 2017
242017
系统目前无法执行此操作,请稍后再试。
文章 1–20